Interaction of heat with X-rays and cis-platinum; cell lethality and oncogenic transformation.
There is increasing concern for the oncogenic potential of agents used to treat cancer. Hyperthermia is one of the few modalities that does not, of itself, produce transformed foci in vitro. The adjuvant use of heat with X-rays or chemotherapy agents is an interesting approach to increasing the cell-killing potential while decreasing the oncogenicity of combined-modality therapy. Following a priming heat dose in C3H 10T1/2 cells, resistance to cell killing by a second heat dose develops and is maximal by 10 h. This is known as thermotolerance, and can be monitored by the appearance of proteins of specific molecular weight known as heat-shock proteins. By contrast, a priming heat dose does not confer resistance to killing by cis-platinum (cis-DDP). Indeed, heat potentiates the cytotoxicity due to cis-DDP. The interaction is greatest if heat and drug are applied simultaneously, but is still substantial if the drug is applied many hours after heating. The loss of interaction between heat and cis-DDP occurs slowly, but by 48 h, heat and drug act independently. Thermotolerant cells are less sensitive to the induction of transformation by X-rays than previously unheated cells. On the other hand, 48 h after a heat exposure, when cells have regained their normal sensitivity to killing by cis-DDP, their sensitivity to the induction of transformation by cis-DDP has also returned to normal.
Miller
R C
RC
Radiological Research Laboratories, College of Physicians & Surgeons of Columbia University, New York, NY 10032.
Roizin-Towle
L
L
Komatsu
K
K
Richards
M
M
Hall
E J
EJ
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000528:radiation effects; D002945:Cisplatin / Q000633:toxicity*; D003131:Combined Modality Therapy; D006360:Heat-Shock Proteins / Q000096:biosynthesis; D006979:Hyperthermia, Induced
D006360:Heat-Shock Proteins; D002945:Cisplatin